Skip to main content
. 2024 Nov 14;14:1469616. doi: 10.3389/fonc.2024.1469616

Table 2.

Adverse events by types and grades.

Incidence Grade I, II Grade III Grade IV
Hematologic
 Neutropenia 1 (5.6%) 6 (33.3%) 3 (16.7%)
 Anemia 0 (0%) 1 (5.6%) 0 (0%)
Non-hematologic
 Generalized weakness 5 (27.8%) 0 (0%) 0 (0%)
 Vomiting 2 (11.1%) 0% (0) 0 (0%)
 Nausea 1 (5.6%) 0 (0%) 0 (0%)
 Ascites 0 (0%) 2 (11.1%) 0 (0%)
 Oral mucositis 0 (0%) 1 (5.6%) 0 (0%)
 Bile duct stenosis 0 (0%) 0 (0%) 1 (5.6%)
 Infection 0 (0%) 1 (5.6%) 0 (0%)
 Fever 1 (5.6%) 0 (0%) 0 (0%)
 Aspiration 0 (0%) 1 (5.6%) 0 (0%)
 Hypoxia 0 (0%) 1 (5.6%) 0 (0%)
 Thromboembolic event 1 (5.6%) 0 (0%) 0 (0%)
 Hypokalemia 1 (5.6%) 0 (0%) 0 (0%)
 Spinal fracture 0 (0%) 1 (5.6%) 0 (0%)
 Dysuria 1 (5.6%) 0 (0%) 0 (0%)
 Injection site reaction 1 (5.6%) 0 (0%) 0 (0%)